Correlation Between Invesco NASDAQ and Innovator IBD

Can any of the company-specific risk be diversified away by investing in both Invesco NASDAQ and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invesco NASDAQ and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Invesco NASDAQ 100 and Innovator IBD 50, you can compare the effects of market volatilities on Invesco NASDAQ and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invesco NASDAQ with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invesco NASDAQ and Innovator IBD.

Diversification Opportunities for Invesco NASDAQ and Innovator IBD

0.87

Correlation Coefficient

Invesco NASDAQ  Innovator IBD

Very poor diversification

The 3 months correlation between Invesco and Innovator is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Invesco NASDAQ 100 and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and Invesco NASDAQ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invesco NASDAQ 100 are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of Invesco NASDAQ i.e., Invesco NASDAQ and Innovator IBD go up and down completely randomly.

Pair Corralation between Invesco NASDAQ and Innovator IBD

Given the investment horizon of 90 days Invesco NASDAQ 100 is expected to generate 0.54 times more return on investment than Innovator IBD. However, Invesco NASDAQ 100 is 1.85 times less risky than Innovator IBD. It trades about 0.07 of its potential returns per unit of risk. Innovator IBD 50 is currently generating about -0.08 per unit of risk. If you would invest  21,179  in Invesco NASDAQ 100 on October 1, 2024 and sell it today you would earn a total of  336.00  from holding Invesco NASDAQ 100 or generate 1.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.24%
Values	Daily Returns

Invesco NASDAQ 100  vs.  Innovator IBD 50

Invesco NASDAQ 100

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Invesco NASDAQ 100 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very sluggish basic indicators, Invesco NASDAQ may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Innovator IBD 50

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Innovator IBD showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Invesco NASDAQ and Innovator IBD

The main advantage of trading using opposite Invesco NASDAQ and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invesco NASDAQ position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.

The idea behind Invesco NASDAQ 100 and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.